investorscraft@gmail.com

Intrinsic ValueKaili Catalyst & New Materials Co.,Ltd. (688269.SS)

Previous Close$46.69
Intrinsic Value
Upside potential
Previous Close
$46.69

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Kaili Catalyst & New Materials Co., Ltd. operates as a specialized manufacturer of precious metal catalysts, primarily utilizing iridium, ruthenium, rhodium, platinum, and palladium. The company's core revenue model is based on the research, development, production, and sale of these high-value catalysts, which serve as critical enabling components across diverse industrial processes. Its products are integral to the synthesis of active pharmaceutical ingredients (APIs), agrochemicals, dyes, and advanced electronic materials, positioning it within the specialty chemicals segment of the basic materials sector. The firm leverages its technical expertise to cater to demanding applications in pharmaceuticals, petrochemicals, and liquid crystal display manufacturing, establishing a niche market position. Operating from its base in Xi'an, China, the company competes by providing essential, performance-critical materials that facilitate complex chemical reactions for its industrial clientele, both domestically and internationally.

Revenue Profitability And Efficiency

For the fiscal period, the company reported revenue of approximately CNY 1.69 billion. Profitability was demonstrated with a net income of CNY 92.6 million, though operating cash flow of CNY 64.9 million was significantly lower, indicating potential working capital investments or timing differences in cash collection relative to recognized earnings.

Earnings Power And Capital Efficiency

The company generated diluted earnings per share of CNY 0.71. Capital expenditure was substantial at CNY -301 million, significantly exceeding operating cash flow and indicating a period of heavy investment in capacity or technological upgrades, which may impact near-term capital efficiency metrics.

Balance Sheet And Financial Health

The balance sheet shows a cash position of CNY 304 million against total debt of CNY 578 million. This debt level, relative to the company's market capitalization and cash generation, suggests a leveraged but manageable financial structure, requiring careful monitoring of interest coverage and liquidity.

Growth Trends And Dividend Policy

The company has demonstrated a shareholder return policy by declaring a dividend of CNY 0.50 per share. The significant capital expenditure outlay suggests a strategic focus on funding future growth initiatives, which may temper short-term dividend growth potential in favor of long-term expansion.

Valuation And Market Expectations

With a market capitalization of approximately CNY 3.01 billion, the market assigns a valuation that reflects its specialized niche and growth prospects. A beta of 0.85 indicates the stock is perceived as slightly less volatile than the broader market, potentially pricing in a degree of stability from its industrial customer base.

Strategic Advantages And Outlook

The company's strategic advantage lies in its deep technical expertise in precious metal catalysis, serving high-value, regulated end-markets. The outlook is tied to its ability to monetize its recent capital investments and maintain its technological edge in the development of new materials for evolving industrial applications.

Sources

Company DescriptionProvided Financial Data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount